Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5085196
Max Phase: Preclinical
Molecular Formula: C44H74N12O9
Molecular Weight: 915.15
Molecule Type: Unknown
Associated Items:
ID: ALA5085196
Max Phase: Preclinical
Molecular Formula: C44H74N12O9
Molecular Weight: 915.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C44H74N12O9/c1-25(2)22-33(40(61)51-27(5)36(57)53-32(43(64)65)17-12-20-49-44(47)48)54-41(62)35-18-13-21-56(35)42(63)34(23-26(3)4)55-37(58)28(6)50-39(60)31(16-10-11-19-45)52-38(59)30(46)24-29-14-8-7-9-15-29/h7-9,14-15,25-28,30-35H,10-13,16-24,45-46H2,1-6H3,(H,50,60)(H,51,61)(H,52,59)(H,53,57)(H,54,62)(H,55,58)(H,64,65)(H4,47,48,49)/t27-,28+,30+,31+,32+,33+,34+,35+/m1/s1
Standard InChI Key: OJODUMIIQGIOJD-CSLZCNNUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 915.15 | Molecular Weight (Monoisotopic): 914.5702 | AlogP: -0.93 | #Rotatable Bonds: 28 |
Polar Surface Area: 346.15 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.61 | CX LogP: -2.71 | CX LogD: -5.67 |
Aromatic Rings: 1 | Heavy Atoms: 65 | QED Weighted: 0.03 | Np Likeness Score: 0.08 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):